Bone marrow failure and Epstein-barr virus associated lymphoproliferative disorder

Summary:

Epstein-barr virus associated lymphoproliferative disorder is reported only by a few people with Bone marrow failure.

The study analyzes which people have Epstein-barr virus associated lymphoproliferative disorder with Bone marrow failure. It is created by eHealthMe based on 3 people who have Epstein-barr virus associated lymphoproliferative disorder and Bone marrow failure from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

3 people who have Bone Marrow Failure and Epstein-Barr Virus Associated Lymphoproliferative Disorder are studied.


What is Bone marrow failure?

Bone marrow failure is found to be associated with 1,511 drugs and 1,335 conditions by eHealthMe.

What is Epstein-barr virus associated lymphoproliferative disorder?

Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus) is found to be associated with 341 drugs and 258 conditions by eHealthMe.

Number of Epstein-barr virus associated lymphoproliferative disorder in Bone marrow failure reports submitted per year:

Would you have Epstein-barr virus associated lymphoproliferative disorder when you have Bone marrow failure?

Gender of people who have Bone Marrow Failure and experienced Epstein-Barr Virus Associated Lymphoproliferative Disorder *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Bone Marrow Failure and experienced Epstein-Barr Virus Associated Lymphoproliferative Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 100 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 3 people, 100.00%
  2. Red Blood Cell Count Decreased: 3 people, 100.00%
  3. Bone Marrow Conditioning Regimen: 3 people, 100.00%

Common drugs taken by these people *:

  1. Ursodiol: 3 people, 100.00%
  2. Tacrolimus: 3 people, 100.00%
  3. Sulfamethoprim: 3 people, 100.00%
  4. Amphotericin B: 3 people, 100.00%
  5. Micafungin Sodium: 3 people, 100.00%
  6. Methylprednisolone Sodium Succinate: 3 people, 100.00%
  7. Itraconazole: 3 people, 100.00%
  8. Voriconazole: 2 people, 66.67%
  9. Heparin Sodium: 2 people, 66.67%
  10. Calcium Gluconate: 2 people, 66.67%

Common symptoms for these people *:

  1. Multi-Organ Failure (multisystem organ failure): 3 people, 100.00%
  2. Histiocytosis Haematophagic: 3 people, 100.00%
  3. Fungal Infection: 3 people, 100.00%
  4. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Epstein-barr virus associated lymphoproliferative disorder?

Check whether Epstein-barr virus associated lymphoproliferative disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Epstein-barr virus associated lymphoproliferative disorder:

Common drugs associated with Epstein-barr virus associated lymphoproliferative disorder:

All the drugs that are associated with Epstein-barr virus associated lymphoproliferative disorder:

Common conditions associated with Epstein-barr virus associated lymphoproliferative disorder:

All the conditions that are associated with Epstein-barr virus associated lymphoproliferative disorder:

How the study uses the data?

The study is based on Epstein-barr virus associated lymphoproliferative disorder and Bone marrow failure, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: